Contact us!     1-877-355-8012  /  info@vielight.com

Vielight Logo
0

Your cart is currently empty.

Vielight Shop
0

Your cart is currently empty.

Vielight Logo
0

Your cart is currently empty.

Is 810nm or 1064nm (1070nm) better for brain photobiomodulation?

Across all age groups, the 810nm wavelength has shown to have a deeper and stronger energy disposition than 1064 nm (1070 nm) in a dosimetry study by Harvard Medical School, Department of Psychiatry and several other universities. Even though 1064 nm (1070 nm) scatters less, it is absorbed more by water molecules, which are abundant in human tissue, especially the brain (70-80% water).

In terms of cellular effects, 810 nm has a stronger effect on mitochondria because photonic absorption by cytochrome c oxidase (CCO) peaks around 810nm and declines as the wavelength gets longer. Direct CCO photoexcitation is weaker at 1064 nm and 1070 nm compared to 810 nm because they are off-peak for mitochondria’s CCO absorption, which peaks around 810 nm.

On the other hand, 1064 nm (1070 nm) has a stronger effect on calcium ion channels, which 810 nm does not have a strong effect on.

The rest of this article, complete with science references, expands more on the differences, covering well-studied biophysics-based biological effects.

Does 810 nm or 1064 nm (1070nm) penetrate deeper into the brain?

According to a transcranial brain photobiomodulation (PBM) study by Harvard Medical School, Department of Psychiatry, the 810nm wavelength has been found to be superior to other wavelengths, which includes higher wavelengths in the 1070nm range for penetration and dosimetry.

According to this study by Harvard Medical School, the order of penetration and dosimetry effectiveness is:

  1. 810 nm – consistently highest across all age groups and regions

  2. 850 nm and 1064 nm – next most effective in most cases

  3. 670 nm and 980 nm – lesser deposition overall

 

This Harvard study is also supported by another brain PBM dosimetry study by leading Chinese universities, comparing 660 nm, 810 nm, 880 nm and 1064 nm. They discovered that the distribution of photon fluence at 660 and 810 nm within the brain was much wider and deeper than 980 and 1064 nm.

The distribution of photon fluence at 660 nm, 810 nm, 980 nm and 1064 nm. Image source: https://doi.org/10.1002/jbio.201800173

The Role of Water Absorption and the First Optical Window in Brain PBM

The differences in dosimetry are supported by a well-established biological principle, the body’s first optical window. While, the 1064 and 1070nm wavelengths are longer and scatter less, they are more strongly absorbed by water, which is abundant in biological tissues, especially the human. The brain consists of 70-80% water, and floats in cerebrospinal fluid (CSF) while the rest of the human body is approximately 60% water. This makes wavelengths like 1064 nm and 1070 nm particularly susceptible to water absorption within the brain.

While 810nm light is preferentially absorbed by chromophores like cytochrome c oxidase in mitochondria and hemoglobin in the blood, 1070nm light is more significantly absorbed by water, which is the primary chromophore for that specific wavelength.

This increased absorption by water can lead to reduced photonic availability and tissue penetration despite the longer wavelength, which the Harvard Medical study and Peking Medical University study reveal. These studies indicate that 810nm has a higher dosimetry than 1064 nm and by extension, 1070 nm.

The body’s optical window. Image source: https://doi.org/10.1016/B978-0-12-815305-5.00005-1

810nm vs 1064nm / 1070nm: Water Absorption and CCO Affinity compared

  • Water Absorption: Light absorption by water increases significantly beyond ~950 nm, and water is abundant in biological tissue. At 1064 nm, absorption by water becomes substantial, which attenuates light more than 810 nm. This increased absorption reduces the effective depth of penetration, especially for energy reaching specific chromophores like cytochrome c oxidase (CCO).
  • Cytochrome c Oxidase (CCO) Absorption: Mitochondria’s CCO’s absorption spectrum peaks around 810 nm, with a notable decrease in absorption towards 1000 nm. This means that 810 nm light is more readily absorbed by CCO compared to 1070 nm.

Visual Proof: Near-Infrared Light Penetrating the Skull with Vielight Neuro

The Vielight Neuro delivers the deepest tissue penetration among brain photobiomodulation devices. In the demonstration video below with the Vielight Neuro, 810 nm near-infrared light—emitted at an irradiance of 250 mW/cm²—can be clearly seen penetrating through the calvaria of a real human skull. This highlights the exceptional transcranial performance of the Vielight Neuro and validates the wavelength’s well-documented ability to reach cortical tissue.

The Vielight Neuro features proprietary Vie-LED technology—highly specialized, custom-engineered LEDs designed to deliver optimal irradiance for brain stimulation without producing excess heat. To ensure safety and efficiency, we’ve intentionally limited the device’s power density to 50% of its maximum potential output. Even still, it features the highest irradiance in the field of brain photobiomodulation according to independent 3rd party tests.

Wwavelengths with greatest CCO Absorption. Image source: https://doi.org/10.1074/jbc.M409650200

Differences in cellular effects between 810nm and 1070nm

810nm has a stronger effect on mitochondria, cytochrome C oxidase (CCO)

The 810nm wavelength is well-known for its strong interaction with cytochrome c oxidase (CCO), a key enzyme in the mitochondrial respiratory chain. By enhancing the activity of CCO, the 810nm wavelength increases ATP production, reduces oxidative stress, and modulates reactive oxygen species (ROS). These effects are crucial for cellular energy metabolism, neuroprotection, and the promotion of cell survival​.

1064 nm and 1070nm has a stronger effect on heat-sensitive ion channels

On the other hand, wavelengths beyond 900nm, such as the 1064nm and 1070nm wavelengths have a weaker effect on mitochondrial CCO but a more direct effect on heat-sensitive ion channels, due to its potential to cause localized heating. Activation of these channels can lead to increased calcium influx, which is crucial for various cellular processes, including neurotransmitter release, gene expression, and neurogenesis.

Why mitochondria absorbs 810 nm more than 1064 nm (1070nm)

1. Spectral absorption properties of cytochrome c oxidase (CCO) within mitochondria

  • Cytochrome c oxidase within mitochondria has distinct absorption bands in the visible red (~660 nm) and near-infrared (810 nm) regions. Studies consistently show that absorption drops off as you shift to longer NIR wavelengths around the 1000 nm range like 1064 nm (1070nm).

  • The absorption bands of CCO become much weaker at wavelengths greater than 900 nm, which suggests that alternative chromophores must exist significantly.

2. Reduced photon availability at 1064 nm (1070 nm)

Why calcium ion channels absorb more 1064 nm (1070nm) versus 810 nm

Calcium channels themselves don’t meaningfully “absorb” 1064 nm light. What happens at ~1064–1070 nm is mainly photothermal couplingwater is absorbed significantly at longer NIR wavelengths (> 1000 nm), producing tiny, rapid temperature rises that gate heat-sensitive TRP calcium channels (e.g., TRPV1/2/4) and/or change membrane capacitance, which in turn drives Ca²⁺ influx.

By contrast, 810 nm couples primarily to cytochrome-c-oxidase (CCO) with much weaker water heating, so Ca²⁺ effects there are usually downstream of mitochondrial signaling, not direct channel gating.

Wavelength alone isn’t enough – irradiance matters.

Irradiance—also referred to as power density or light intensity – is a measure of how much light energy reaches a surface per unit area, typically expressed in milliwatts per square centimeter (mW/cm²). In photobiomodulation (PBM), including brain PBM, irradiance determines how much photonic power is delivered to the tissue.

While using an effective wavelength (such as 810 nm, 1064 nm, or 1070 nm) is essential for targeting chromophores like cytochrome c oxidase, the biological response and penetration depth depends just as much on irradiance. Without sufficient power density, even the correct wavelength may fail to penetrate tissue effectively or trigger meaningful cellular effects. Low irradiance can result in sub-therapeutic penetration and doses, while excessively high irradiance may lead to phototoxicity or energy wastage.

Data Source: The PBM Foundation’s Device Testing Portal - https://pbmfoundation.org/pbm-device-testing-portal/

A Comparative Snapshot

In a 2024 systematic review that screened 2,133 records and included 97 brain-PBM studies, reported power densities typically clustered around ~250 mW/cm² (especially under physiological conditions).

This is a snapshot comparison of independently measured irradiance by photonics labs by the PBM Foundation between commercial devices with the 810nm wavelength and the 1064 nm, 1070nm wavelengths.

The PBM Foundation benchmarked the Vielight Neuro 3 against two PBM helmets, the Suyzeko NIR helmet and Neuronic Neuradiant twice, as case studies for their testing program to standardize irradiance reporting.

MegaLab and Optronic Lab, photonics engineering firms, conducted the tests:

  1. Read the full independent test report from Optronic Lab here.
  2. Read the full independent test report from MegaLab here.
Source Independently measured irradiance Manufacturer % of Typical Brain-PBM Irradiance (≈250 mW/cm²)
Vielight Neuro (Vielight) 180-350 mW/cm2 Vielight, Canada 80–160%
Neuradiant 1070 (Neuronic) 9 mW/cm2 Suyzeko, China
(Private-labelled)
≈4%
Suyzeko PBM Helmet (Suyzeko) 5 mW/cm2 Suyzeko, China 3%
Natural Sunlight 100 mW/cm2 Free 40%

Number of published clinical studies

Vielight technology is featured in the most published research by a significant margin for the reasons above.

Be cautious of companies attributing research conducted with Vielight devices or other devices as attainable to their own.

Brain photobiomodulation is parameter-specific and our Vie-LED technology generates a unique laser-like profile and an industry-leading irradiance.

The table below is a benchmark studies published comparison against other random PBM helmets.

 

Technology Independently measured wavelength Research Manufacturer Medical Grade
Vielight Neuro (Vielight) 810nm 30 published
(17 ongoing)
Vielight, Canada Yes
Neuradiant 1070 (Neuronic) 1059nm 3 published Suyzeko, China
(Private-labelled)
No
Suyzeko PBM Helmet (Suyzeko) 811nm 1 published Suyzeko, China No

Conclusion

Both 810 nm and 1070 nm wavelengths are widely used in brain photobiomodulation (PBM), and emerging evidence suggests each has distinct advantages depending on the clinical context. Numerous independent studies have focused on 810 nm, with consistent positive outcomes in mitochondrial activation, neuroprotection, and cognitive benefits. In contrast, research using the 1070 nm range—such as 1064 or 1070 nm—though less abundant, shows similar therapeutic potential and quality when conducted.

Vielight’s selection of 810 nm is rooted in its lower absorption by hemoglobin and water, enabling deeper and more efficient penetration through scalp, skull, and brain tissue than higher wavelengths like 1070 nm. Recent peer-reviewed comparisons—including work by Harvard Medical School—confirm that 810 nm reaches deeper brain structures under comparable power density conditions, making it the best wavelength for brain photobiomodulation based on current literature.

While 1064 nm and 1070 nm may offer slightly better photon scattering properties for deep tissue delivery, especially in neurological conditions, mitochondrial stimulation efficacy tends to be stronger with 810 nm, owing to its specific absorption by cytochrome c oxidase and related chromophores. That means while both wavelengths are effective, 810 nm is often seen as optimal for combining depth with bioenergetic stimulation, whereas 1064 nm 1070 nm is a reasonable alternative for the effects on calcium ions.

However, both 810 nm and 1070 nm wavelengths require strong irradiance levels to achieve therapeutic efficacy, particularly when targeting brain tissue. This is because transcranial photobiomodulation must overcome several biological barriers—including the scalp, skull, and cerebrospinal fluid—before sufficient light can reach neuronal structures. Higher irradiance (measured in mW/cm²) ensures that enough photons penetrate these layers and maintain adequate energy density at depth to activate key chromophores such as cytochrome c oxidase. Without sufficient irradiance, even an optimally chosen wavelength may fail to deliver meaningful biological effects.

References

  1. Hale, G. M., & Querry, M. R. (1973). “Optical Constants of Water in the 200 nm to 200 µm Wavelength Region.” Applied Optics, 12(3), 555-563.
  2. Hamblin, M. R. (2016). “Mechanisms and applications of the anti-inflammatory effects of photobiomodulation.” A comprehensive review discussing how specific wavelengths, particularly in the 800-850nm range, are absorbed by cytochrome c oxidase, leading to enhanced mitochondrial function and anti-inflammatory effects.
  3. Dompe C, Moncrieff L, Matys J, Grzech-Leśniak K, Kocherova I, Bryja A, Bruska M. Photobiomodulation-Underlying Mechanism and Clinical Applications. J Clin Med. 2020 Jun 3;9(6):1724. doi: 10.3390/jcm9061724. PMID: 32503238; PMCID: PMC7356229.
  4. Wu, C., Yang, L., Feng, S. et al. Therapeutic non-invasive brain treatments in Alzheimer’s disease: recent advances and challenges. Inflamm Regener 42, 31 (2022). https://doi.org/10.1186/s41232-022-00216-8
  5. Mason MG, Nicholls P, Cooper CE. Re-evaluation of the near infrared spectra of mitochondrial cytochrome c oxidase: Implications for non invasive in vivo monitoring of tissues. Biochim Biophys Acta. 2014 Nov;1837(11):1882-1891. doi: 10.1016/j.bbabio.2014.08.005. Epub 2014 Aug 29. PMID: 25175349; PMCID: PMC4331044.
  6. Huang, Y. Y., Sharma, S. K., Carroll, J., & Hamblin, M. R. (2011). “Biphasic dose response in low-level light therapy.” This study discusses the interaction between different wavelengths (including 810nm) and mitochondrial chromophores such as cytochrome c oxidase, with a focus on dose-response relationships in photobiomodulation therapy.
  7. Rojas, J. C., & Gonzalez-Lima, F. (2011). “Low-level light therapy of the eye and brain.” This paper provides an overview of how different wavelengths, including 810nm, affect mitochondrial respiration and neurogenesis, highlighting the specificity of cytochrome c oxidase absorption and the differential effects based on wavelength.
  8. Yuan Y, Cassano P, Pias M, Fang Q. Transcranial photobiomodulation with near-infrared light from childhood to elderliness: simulation of dosimetry. Neurophotonics. 2020 Jan;7(1):015009. doi: 10.1117/1.NPh.7.1.015009. Epub 2020 Feb 24. PMID: 32118086; PMCID: PMC7039173.
  9. Wang, P., & Li, T. (2019). Which wavelength is optimal for transcranial low‑level laser stimulation? Journal of Biophotonics, 12(2), e201800173. https://doi.org/10.1002/jbio.201800173
  10. Wang X, Tian F, Reddy DD, Nalawade SS, Barrett DW, Gonzalez-Lima F, Liu H. Up-regulation of cerebral cytochrome-c-oxidase and hemodynamics by transcranial infrared laser stimulation: A broadband near-infrared spectroscopy study. J Cereb Blood Flow Metab. 2017 Dec;37(12):3789-3802. doi: 10.1177/0271678X17691783. Epub 2017 Feb 9. PMID: 28178891; PMCID: PMC5718323.
  11. Wang Y, Huang YY, Wang Y, Lyu P, Hamblin MR. Photobiomodulation of human adipose-derived stem cells using 810nm and 980nm lasers operates via different mechanisms of action. Biochim Biophys Acta Gen Subj. 2017 Feb;1861(2):441-449. doi: 10.1016/j.bbagen.2016.10.008. Epub 2016 Oct 15. PMID: 27751953; PMCID: PMC5195895.
  12. Hashmi, J. T., Huang, Y. Y., Osmani, B. Z., Sharma, S. K., Naeser, M. A., & Hamblin, M. R. (2010). “Role of low-level laser therapy in neurorehabilitation.” This article reviews the use of 810nm and other near-infrared wavelengths in neurorehabilitation, discussing the potential for cortical neurogenesis, anti-inflammatory effects, and the differences in penetration and cellular response between wavelengths.
  13. Eells, J. T., Henry, M. M., Summerfelt, P., Wong-Riley, M. T., Buchmann, E. V., Kane, M., … & Whelan, H. T. (2003). “Therapeutic photobiomodulation for methanol-induced retinal toxicity.” Although focused on retinal applications, this study provides insights into how different wavelengths interact with mitochondrial function, particularly in terms of cytochrome c oxidase activation.
  14. “Introduction to Solar Radiation”. Newport Corporation. Archived from the original on October 29, 2013.

Published:

This article was written by

Dr. Genane Loheswaran

Vielight | Research Manager and Neuroscientist

Genane manages Vielight’s research projects with various organizations for cognitive science, such as combining photobiomodulation with EEG.

MSc in Neuroscience, McMaster University
PhD in Pharmacology, University of Toronto
Meet the author
0